about
Alzheimer Disease and MortalityApoptotic interactions of cytochrome c: redox flirting with anionic phospholipids within and outside of mitochondriaMild cognitive impairment: pathology and mechanisms.Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's diseaseAssociation studies of 22 candidate SNPs with late-onset Alzheimer's diseaseRarity of the Alzheimer disease-protective APP A673T variant in the United StatesThree SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's diseaseReduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correctionTraumatic brain injury--football, warfare, and long-term effectsCommon variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.Genome-wide association analysis of age-at-onset in Alzheimer's diseaseGenome-wide association study of Alzheimer's diseaseResearch criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteriaCerebral [18 F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy.Inflammatory Biomarkers and Cognitive Decline: The Ginkgo Evaluation of Memory Study.[18F]-T807 tauopathy PET imaging in chronic traumatic encephalopathy.2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.Genetic Determinants of Survival in Patientswith Alzheimer’s Disease.Markers of cholesterol transport are associated with amyloid deposition in the brain.Genetic determinants of disease progression in Alzheimer's diseaseArterial stiffness and β-amyloid progression in nondemented elderly adults.Chronic traumatic encephalopathy: clinical-biomarker correlations and current concepts in pathogenesis.Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury.Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults.Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study.Cerebral blood flow changes after brain injury in human amyloid-beta knock-in miceClassification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.Association between performance on Neurology In-Training and Certification Examinations.Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory studyToward the treatment and prevention of Alzheimer's disease: rational strategies and recent progressGray matter atrophy associated with extrapyramidal signs in the Lewy body variant of Alzheimer's disease.Association of CLU and PICALM variants with Alzheimer's disease.Acute blast injury reduces brain abeta in two rodent species.Trends in American Board of Psychiatry and Neurology specialties and neurologic subspecialties.Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease.Replication study of genome-wide associated SNPs with late-onset Alzheimer's diseaseTemporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapyThe CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study.Is the urea cycle involved in Alzheimer's disease?
P50
Q22253053-081C321C-F14D-4EFA-A72E-D011EE29B42CQ23913323-6E448331-79DB-47FB-B811-A242D4DE73E4Q24631255-C869C1CB-6354-431F-98B3-8D60BEF2B8D2Q24631387-0E3FB2BC-292F-4F0C-ACD5-152B006B571BQ24647572-E61CDEE0-57B9-47E7-AEBC-A56554C6ACD9Q27346292-5A8C899F-EF53-40EA-BA42-0671F82611EBQ28252877-357778E2-F7CC-4CFF-B9C3-C7A88B96FE2EQ28289499-D6A103D8-4948-44F7-B776-5054A7928AA7Q28294364-81C85C18-F19D-4105-9E8A-CE7C901DFBD7Q28943325-7D954D9C-E0FF-4F89-87E6-6963B05BEEE3Q29417033-B8085DCE-57E1-47B4-A957-2B59FA052CFBQ29417071-404D0AB1-C0DA-49FA-9B19-84A60DC3C950Q29614408-2CAD4167-AFC9-4D24-B5F7-1FE78C08A8CCQ30275833-5B9A8E39-02C0-4E35-AF94-AEBCCFA3BFEFQ30276553-F475BE33-DAAC-432B-ADC1-381EE45F5B48Q30301175-3E7C8076-6E0E-48C8-BDFC-3B0A4DE5B5EAQ30303063-72F9F0B2-F14C-4894-ABFE-842CF54483C0Q30361780-20DD9921-EA78-41B9-AB7B-CD537CC64416Q30406139-F002370E-FAAE-4D10-AE8B-C5B5A0DD97D6Q30408805-83A18525-39AC-49AB-8391-113AF1B5088BQ30409084-92D1546D-88E8-445B-A87D-1BA07423C731Q30409194-6EE1A989-79C4-43A0-A88E-59A0750575A5Q30409615-99025D28-7951-4E6E-949D-040B68CCDE56Q30409644-711E78D7-4431-4003-9803-2342A6F7AF1CQ30410885-BE5221AD-67D9-4742-B5E4-4354F55AF60EQ30412815-6E75572B-18B9-4CEC-9028-33F74CFF0AD3Q30413572-A24064B0-AA18-4717-A330-DAABF5948B3FQ30415386-F8259783-9BE5-431A-8816-9AB4B5D21E19Q30417962-6A48C83D-4585-4CC6-939A-63906DB97EA0Q30419992-1C538A33-EE64-4F2D-BFD8-D1D041EC485CQ30421996-F5FE2147-EE2A-434B-B9B5-40A46956DEDCQ30422270-4FDAEC68-6AAB-477D-B1AA-889297B4F8A2Q30423253-79574405-4E18-49C2-A418-1AC4FC31E782Q30424635-5BE41F30-D1E8-4B93-BEA8-54E30A6DEF4AQ30426091-EF8FBFEE-9C70-49C3-B8FF-1710851DD2DEQ30426556-8B3B699C-7685-4618-9229-E24CAB3CFB7FQ30428012-EFFE6043-64AD-48BE-B347-DB10478E7988Q30432684-CF0714BA-3FAD-4357-A9A7-148114A2FC96Q30433658-EE1952F9-62B4-4278-92B9-9B7D63BD156EQ30433662-0433443B-C5E4-4B2D-942A-86D684C8FF75
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Steven T Dekosky
@ast
Steven T Dekosky
@en
Steven T Dekosky
@es
Steven T Dekosky
@nl
type
label
Steven T Dekosky
@ast
Steven T Dekosky
@en
Steven T Dekosky
@es
Steven T Dekosky
@nl
altLabel
Steven DeKosky
@en
Steven T DeKosky
@en
prefLabel
Steven T Dekosky
@ast
Steven T Dekosky
@en
Steven T Dekosky
@es
Steven T Dekosky
@nl
P106
P31
P496
0000-0003-3743-2758